Moulay   Alaoui-Jamali

Professor

Oncology; Medicine;
Pharmacology & Therapeutics

Dundi and Lyon Sachs Distinguished Scientist

Address:
Segal Cancer Centre and
Lady Davis Institute for Medical Research
Room E525
Jewish General Hospital
3755, chemin Côte Ste-Catherine
Montreal, QC H3T 1E2

Telephone: (514) 340-8222 X 23438
E-mail: moulay.alaoui-jamali@mcgill.ca
Website

Education: PhD (Doctorat d'Etat Es-Sciences médicales), René-Descartes and Lariboisiere/Sorbonne Université et Institut National de Recherches sur le Cancer, Paris and National Cancer Institute, Villejuif, France

Research Focus: Cancer progression: Metastasis signalling; Preclinical cancer models; Drug and Target Discovery; Drug pharmacology


Recent Presentations:

Genome-wide analysis of Rab GTPases as biomarkers for metastatic OSCC and early translation for potential therapeutic applications. 2nd Austrian Biomarker Symposium 2014; March 31 - April 1, 2014; Vienna, Austria.

Selective Inhibition of Heme Oxygenase 1 Enzyme Induces Antitumor Activity and Synergizes with Taxanes in Preclinical Cancer Models. The Innovations of Oxidative Stress, Redox Modulation and Antioxidants in 2014: Targeting Chronic Diseases; 14th International Conference on Oxidative Stress Reduction, Redox States & Antioxidants June 12-13, 2014 - Paris – France.

Genome-Wide Analysis of Rab GTPases in Metastatic Oral Squamous Carcinoma. 5th World Congress of IFHNOS & Annual Meeting of the American Head and Neck Society. Marriott Marquis, New York City, July 26-30, 2014.

Co-overexpression of specific ErbB receptor combinations predicts poor outcomes in pN+ squamous cell carcinoma with capsular ruptura. 5th World Congress of IFHNOS & Annual Meeting of the American Head and Neck Society. Marriott Marquis, New York City, July 26-30, 2014.

Advances in the discovery of cell reprogramming therapeutics for cancer and regenerative medicine. 2014 International Hepatobiliary & Pancreatic Diseases Summit Forum September 4-6, 2014; Shaoxing, China

Next-generation therapeutics for metastatic breast cancer and perspectives on clinical translation (Session: Triple negative breast cancer). The first conference of Medical Oncology of Marrakech- New developments in Cancer Management and Personalized Cancer Care, Nov. 27-29, 2014; Marrakech, Morocco

Recent Publications:

Please click here for Dr. Moulay Alaoui-Jamali's complete publication list.